Literature DB >> 2827342

Isolation of the lipoprotein associated coagulation inhibitor produced by HepG2 (human hepatoma) cells using bovine factor Xa affinity chromatography.

G J Broze1, L A Warren, J J Girard, J P Miletich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2827342     DOI： 10.1016/0049-3848(87)90422-1

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2.

Authors:  T J Girard; D McCourt; W F Novotny; L A MacPhail; K M Likert; G J Broze
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

2.  Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.

Authors:  A E Mast; D A Higuchi; Z F Huang; I Warshawsky; A L Schwartz; G J Broze
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

3.  The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.

Authors:  I Warshawsky; G Bu; A Mast; J E Saffitz; G J Broze; A L Schwartz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 4.  Tissue factor; from Morawitz to microparticles.

Authors:  Nigel S Key; Jian-Guo Geng; Ronald R Bach
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

Review 5.  Tissue factor pathway inhibitor: structure-function.

Authors:  George J Broze; Thomas J Girard
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.